Phase III MARIPOSA: amivantamab + lazertinib vs osimertinib in EGFR-mutated NSCLC VJOncology 3:17 11 months ago 1 404 Далее Скачать
MARIPOSA: follow-up of lazertinib with amivantamab or osimertinib in EGFR-m NSCLC VJOncology 1:27 1 month ago 88 Далее Скачать
MARIPOSA-2: amivantamab + chemo (± lazertinib) vs chemo in EGFR-mutated NSCLC post-osimertinib VJOncology 2:04 11 months ago 749 Далее Скачать
MARIPOSA: longer-term follow-up of amivantamab & lazertinib in EGFR-m NSCLC VJOncology 6:15 3 weeks ago 51 Далее Скачать
Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2 European Society for Medical Oncology (ESMO) 4:17 11 months ago 1 593 Далее Скачать
MARIPOSA Update - Amivantamab + Lazertinib in 1L EGFR mutated metastatic NSCLC. OncBrothers: Practice-Changing Cancer Discussions 0:55 3 months ago 302 Далее Скачать
PALOMA-3: subcutaneous vs intravenous amivantamab + lazertinib in refractory EGFR-mutated NSCLC VJOncology 3:27 4 months ago 224 Далее Скачать
MARIPOSA: mechanisms of resistance to 1L amivantamab + lazertinib in pts with EGFR-m NSCLC VJOncology 2:08 1 month ago 126 Далее Скачать
Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC VJOncology 2:03 2 years ago 648 Далее Скачать
The future of amivantamab and lazertinib in EGFR-mutant NSCLC VJOncology 0:47 10 months ago 212 Далее Скачать
Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC European Society for Medical Oncology (ESMO) 5:18 11 months ago 1 879 Далее Скачать
Post-progression analysis of MARIPOSA-2: amivantamab + chemo in EGFR+ NSCLC VJOncology 3:21 5 months ago 241 Далее Скачать
First line treatment options for activating EGFR non-small cell lung Cancer | Dr. Alexander Spira OncBrothers: Practice-Changing Cancer Discussions 0:58 10 months ago 177 Далее Скачать
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC ecancer 9:54 3 years ago 978 Далее Скачать
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC ecancer 16:45 3 years ago 1 317 Далее Скачать
Dr. Gadgeel Discusses Updated MARIPOSA Results at IASLC 2024 World Conference on Lung Cancer Lung Cancers Today 6:56 1 month ago 41 Далее Скачать
PAPILLON Phase III primary results: amivantamab + chemo vs chemo in EGFR Exon 20 NSCLC VJOncology 1:27 11 months ago 327 Далее Скачать
Second line treatment in activating EGFR non-small cell lung cancer, MARIPOSA - 2 | Onc Brothers OncBrothers: Practice-Changing Cancer Discussions 0:56 10 months ago 215 Далее Скачать
New Standard of care Treatment for EGFR Exon 20 Non-small cell Lung Cancer | Dr. Alexander Spira OncBrothers: Practice-Changing Cancer Discussions 0:59 10 months ago 277 Далее Скачать
Amivantamab Plus Lazertinib for EGFR-Mutant Lung Cancer Following Progression on Osimertinib PracticeUpdate 9:02 3 years ago 698 Далее Скачать
